Chinese pharma company Jiangsu Hengrui Pharmaceuticals has granted USA-based ONEBIO exclusive rights to its anti-TSLP monoclonal antibody SHR-1905 in a deal cov 15 August 2023
US biotech major Gilead Sciences has presented data to show that twice-yearly Sunlenca (lenacapavir) has a sustained impact on health-related quality of life in 25 July 2023
Healthcare investor TVM Capital Life Science has joined forces with Tillotts Pharma to launch a new biotech company, Mage Biologics, backed by $28 million in fi 21 July 2023
Dublin-headquartered protein specialist Prothena has outlined research it intends to present at the upcoming Alzheimer’s Association International Conference (A 12 July 2023
French biotech Abionyx Pharma will treat a fourth patient with its rare kidney disease candidate CER-001, following a compassionate access authorization (CAA). 11 July 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.